Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
Clinical trial NCT03304080 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03304080
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2027-07-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.